Latest Market Reports - Page 1036 of 1123 - Latest Market Insights and Trends

Central Venous Catheters To Experience Sharp Incline Amid Greater Effectiveness : Fact.MR

Post author By administrator
Post date September 10, 2021

Award-winning consulting firm Fact.MR recently published a report on the global venous procedure devices market, for the forecast period 2021-2031. According to the study, the market is projected to surpass US$ 3 billion in value by the end of the aforementioned forecast period (2021 to 2031), expanding at a CAGR of around 6%. Growth is majorly influenced by an increase in vascular disease procedures.

Historically, the market posted credible gains, being valued at around US$ 2 billion in 2019. A host of established as well as incumbent market players are scrambling to secure a firm footing in the landscape. AIincreasing number of startups are capitalizing on incremental opportunities presented by key segments across the venous procedure devices market.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=5966

Inari Medical, for instance, offers the Flow Triever catheter-based thrombectomy device shown to extract significant amounts of clot from large blood vessels. It has a self-expanding Nitinol framework designed to engage, disrupt and remove emboli from blood vessels with minimal trauma. Likewise, Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Its products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system.

Key Takeaways from Market Study

By product, central venous catheters to experience sharp incline amid greater effectiveness
By application, chest venous procedure devices to remain dominant, abdomen devices uptake expanding rapidly
Venous procedure devices for vascular diseases will experience robust incline through 2031
By end user, hospitals to remain primary source of venous procedure devices implanting
The U.S. to emerge as a potential growth hotspot amid increased prevalence of peripheral arterial disease
India to cement its dominance across the South Asian market

“Purpose-built venous stents offer promising growth prospects, attributed to their ability to achieve efficient arterial pulsation and mobility for treating occlusion diseases. Hence, prominent manufacturers are collaborating with medical technology consulting firms to deepen their outreach,”comments a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=5966

Key Market Segments Covered

Product
- Venous Stents
  - Drug-eluting Venous Stents
  - Non-drug Eluting Venous Stents
- Venous Procedure Catheters
  - Central Venous Catheters
  - Subcutaneous (Implanted) Venous Port Catheters
  - Peripherally Inserted Central Venous Catheters (PICC)
- Venous Procedure Guidewires
  - Standard Venous Procedure Guidewires
  - High Support Venous Procedure Guidewires
  - Flexible Venous Procedure Guidewires
  - Chronic Total Occlusion Venous Procedure Guidewires
- Others
Application
- Leg Venous Procedure Devices
- Chest Venous Procedure Devices
- Abdomen Venous Procedure Devices
- Arm Venous Procedure Devices
Indication
- Venous Procedure Devices for Vascular Diseases
  - Chronic Deep Vein Thrombosis
  - Post-thrombotic Syndrome
  - May-Thurner Syndrome
  - Hemodialysis/Arteriovenous Fistulae
  - Others
- Venous Procedure Devices for Cancer
End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Region
- North America (US and Canada)
- Europe (Germany, UK, France, Italy, Spain and Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia & New Zealand and Rest of Asia-Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (GCC, South Africa and Rest of MEA)

Full Access of this Report Is Available at https://www.factmr.com/checkout/5966

Competitive Landscape

Medtronic Plc., Abbott Laboratories, Cook Medical, Cardinal Health, Becton Dickinson & Co. (BD), Terumo Corporation, Boston Scientific Corporation and Teleflex are some prominent venous procedure devices manufacturers. Most players rely on introducing new devices post regulatory approvals across key geographies, in addition to other expansion strategies such as collaborations, mergers & acquisitions and partnerships respectively.

For instance, in May 2019, Cordis, a Cardinal Health company, announced the full US launch of its RADIAL 360 portfolio, offering a complete range of products to facilitate the tranradial approach (TRA) for interventional cardiology. The portfolio consists of RAIN SheathTM Transradial Thin-Walled Introducer, RAILWAYTM Sheathless Access System and the ZEPHYR® Vascular Compression Brand among others
In April 2021, Becton Dickinson (BD) announced enrollment in its post-market studies of the WavelinQTM Arteriovenous Endovascular Fistula device which uses concomitant ulnar artery and ulnar vein in patients suffering from chronic kidney diseases, expected to enroll 280 participants through 30 days

For More Insights https://www.biospace.com/article/new-product-developments-in-biologics-will-turn-game-changer-for-acromegaly-treatment-market-expects-fact-mr/

More Valuable Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the venous procedure devices market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (stents, catheters, and others), application (leg, chest, abdomen, and arm), indication (vascular diseases and cancer), and end user (hospitals, ambulatory surgical centers, specialty clinics, and others) across five major regions of the world (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Venous Procedure Devices Market, Venous Procedure Devices Market Share, Venous Procedure Devices Market Size, Venous Procedure Devices Market Trends

Pharmaceutical

Continuous Hyperthermia Cancer Treatment Market: Rising Cancer Prevalence Is Attributed as the Chief Growth Driver for this Market

Post author By administrator
Post date September 10, 2021

Award-winning consulting firm Fact.MR has recently published an extensive report on the global market for hyperthermia cancer treatment for the forecast period of 2021-2031. According to the study, the market is anticipated to accrue impressive gains, expanding at a CAGR of around 6% to surpass a valuation of US$ 250 million by 2031. Rising cancer prevalence is attributed as the chief growth driver for this market.

The International Agency for Research on Cancer (IARC) estimates that, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease, respectively. These new estimates suggest that more than 50 million people are living within five years of a past cancer diagnosis. Also, according to the World Health Organization, breast cancer is the most commonly occurring cancer in women and the second-most common cancer overall. Over 2 million new cases of breast cancer were diagnosed across the world in 2018. Hence, the scope for incorporating sophisticated treatments is increasing, paving way for enhanced adoption of hyperthermia cancer treatment.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=5877

Furthermore, various governmental initiatives to fund extensive cancer research programs are proving to be a boon for market growth. For instance, in April 2016, the U.S. Government allotted US$ 5.2 billion to the National Cancer Institute (NCI) for cancer research and training. This has enabled the U.S. healthcare system to deploy a host of advanced cancer treatment and diagnosis solutions.

Key Take aways from Market Study

Microwave hyperthermia cancer treatment devices to account for over 40% revenue share through 2031
By application, treatment for breast cancer to remain key revenue generator
Prospects for deep tissue ®ional perfusion appear highly promising, expected to post significant gains
By enduser, hospitals to yield over two-fifth of the global revenue share through 2031
High cancer incidence and prevalence rates to stimulate demand across the U.S.
The U.K. to stimulate high demand amid growing preference for minimally invasive cancer treatment
Rapid advancements in medical technology to bolster uptake across France and Germany

“Rising demand for improving clinical outcomes and inflicting minimal patient discomfort is prompting healthcare providers to deploy a broad range of advanced surgical and therapeutic options, including high intensity focused ultrasound (HIFU), widening the growth prospects of market players,” says a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=5877

Key Market Segments Covered

Device
- Infrared Devices for Hyperthermia Cancer Treatment
- Magnetic Hyperthermia Devices
- Ultrasound Hyperthermia Devices
- Microwave Devicesfor Hyperthermia Cancer Treatment
- Others
Treatment Method
- Loco-regional Method
- External & Interstitial
- Intraluminal or Endocavitary Methods
- Continuous Hyperthermic Peritoneal Perfusion (CHPP)
- Deep Tissue & Regional Perfusion
- Whole Body
Application
- Breast Cancer
- Liver Cancer
- Soft Tissue Sarcoma
- Head & Neck Tumors
- Prostate Cancer
- Others
End User
- for Hyperthermia Cancer Treatment at Hospitals & Specialty Clinics
- for Hyperthermia Cancer Treatment at Ambulatory Surgical Centers
- Others
Region
- North America
  - US
  - Canada
- Europe
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Rest of Europe
- Asia-Pacific
  - Japan
  - China
  - India
  - Australia & New Zealand
  - Rest of APAC
- Latin America
  - Brazil
  - Mexico
  - Rest of Latin America
- Middle East & Africa
  - GCC
  - South Africa
  - Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/5877

Competitive Landscape

Fact.MR’s has profiled the following hyperthermia cancer treatment solution providers in its research report: PYREXAR Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd., Gamida-Cell Ltd., and RanD. Some key expansion strategies deployed by the afore mentioned players include strengthening distribution networks and introducing new approaches to treat and diagnose potential cancers.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the hyperthermia cancer treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of device (infrared devices, ultrasound devices, microwave devices, and others), treatment method (loco-regional and whole body), application (breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others) and enduser (hospitals & specialty clinics, ambulatory surgical centers, and others) across five major regions of the world (North America, Europe, Latin America, AsiaPacific, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/increasing-levels-of-adoption-and-cosmetology-related-demands-will-drive-skin-cooling-systems-market-to-greater-lengths-expects-fact-mr/

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Hyperthermia Cancer Treatment Market, Hyperthermia Cancer Treatment Market Insights, Hyperthermia Cancer Treatment Market Share, Hyperthermia Cancer Treatment MarketSize

Pharmaceutical

Sales of Liquid/Fluid Aseptic Transfer Systems are Gaining Traction with Increasing Demand from Pharmaceutical Companies

Post author By administrator
Post date September 10, 2021

Sales of aseptic transfer systems are gaining traction with increasing demand from pharmaceutical companies, research laboratories, and other key end-use sectors. As the requirement for liquid transfer systems and solid transfer systems is becoming prominent across the world, aseptic transfer system manufacturers are expected to experience higher growth over the coming years, with the pharmaceutical sector being the main end user.

According to a new report by Fact.MR, North America, Europe, and Asia Pacific will remain major markets for aseptic transfer systems, while the overall industry value will surpass a valuation of US$ 1.5 billion by 2031, expanding at a healthy CAGR of 6.5% over the next ten years.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6088

Key Takeaways from Market Study

High demand for liquid transfer systems likely to be witnessed.
Increase in demand from pharmaceutical sector to boost overall sales.
The United States to lead demand for aseptic transfer systems in North America.
Germany to take center stage in Europe’s market for aseptic transfer systems.
Asia Pacific to emerge as the fastest-growing market for aseptic transfer systems.
China, Japan, the United Kingdom, India, France, and Canada to maintain positive industry outlook during the forecast period.

“As the pharmaceutical sector is becoming more advanced, demand for aseptic transfer systems is surging. Additionally, rising preference for single-use aseptic transfer systems is set to propel the growth of suppliers further over the coming years,”says a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6088

aseptic transfer system market

Market Segmentation by Category

Product
- Liquid/Fluid Aseptic Transfer Systems
- Solid/ Powder Aseptic Transfer Systems
Usability
- Single-use Aseptic Transfer Systems
- Multiple-use Aseptic Transfer Systems
End User
- Aseptic Transfer Systems for Pharmaceutical Companies
- Aseptic Transfer Systems for Research Laboratories
- Aseptic Transfer Systems for Hospitals
- Others
Region
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania

Full Access of this Report Is Available at https://www.factmr.com/checkout/6088

Pharmaceutical Sector to Lead Demand for Aseptic Transfer Systems

Aseptic transfer systems are highly sought-after in the pharmaceutical sector for the secure transfer of fluids, components, powders, and others. With increase in adoption of advanced technologies by the pharmaceutical sector, suppliers of aseptic transfer systems are subject to come across lucrative growth scope in the near future.

According to a report published by SelectUSA, the United States pharmaceutical sector is one of the largest in the world, while U.S. firms conduct over half the world’s research & development (R&D) in pharmaceuticals, which is worth US$ 75 billion. As stated in a report published by the European Medicines Agency, Europe’s pharmaceutical industry is highly progressive and projected to grow significantly, owing to increasing investments by governments and various initiatives. These factors give a glimpse of the growing opportunities for aseptic transfer system suppliers around the world.

Who is Winning in this Space?

The global aseptic transfer system market is fragmented and flourishing on the back of key industry players. In order to sustain their leading positions, key market players are focusing on the quality and quantity of their products.

For instance,

Getinge AB recently launched its new range of DPTE® Sterile Transfer System, DPTE-BetaBag®, and others.
Flexifill Ltd. launched its new range of Flexifill Aseptic Filling Solutions, Aseptic Product Transfer Solutions, and others, a couple of years back.

For More Insights https://www.biospace.com/article/extended-wear-contact-lens-sales-encouraged-by-rising-e-commerce-industry-says-fact-mr/

More Valuable Insights

In its latest report, Fact.MR offers an unbiased analysis of the aseptic transfer system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (liquid transfer systems and solid transfer systems), usability (single use and multiple use), and end-use industry (pharmaceutical companies, research laboratories, and others), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Aseptic Transfer System Market, Aseptic Transfer System Market growth, Aseptic Transfer System Market Insights

Pharmaceutical

Oncology Small Molecule Drugs Market to Expand at a Healthy CAGR of 6% through 2031

Post author By administrator
Post date September 9, 2021

Oncology Small Molecule Drugs Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Oncology Small Molecule Drugs insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Oncology Small Molecule Drugs market and quantified with insightful rationale.

A comprehensive estimate of the Oncology Small Molecule Drugs market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Oncology Small Molecule Drugs during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=3747

Key Segments Covered

Route of Administration
- Oral Oncology Small Molecule Drugs
- Injectable Oncology Small Molecule Drugs
Drug Class
- Small Molecule Chemotherapy Drugs
  - Alkylating Drugs
  - Antimetabolites
  - Other Drugs
- Small Molecule Immunomodulating Drugs
- Small Molecule Targeted Therapy Drugs
  - Proteasome Inhibitors
  - Tyrosine Kinase Inhibitors
  - mTOR Inhibitors
  - Hormonal Therapy
Distribution Channel
- Oncology Small Molecule Drugs Distribution via Hospital Pharmacies
- Oncology Small Molecule Drugs Distribution via Retail Pharmacies
- Oncology Small Molecule Drugs Distribution via Specialty clinics
- Oncology Small Molecule Drugs Distribution via Online Pharmacies
Indication
- Oncology Small Molecule Drugs for Non-small Cell Lung Cancer
- Oncology Small Molecule Drugs for Renal Cell Carcinoma
- Oncology Small Molecule Drugs for Breast Cancer
- Oncology Small Molecule Drugs for Prostate Cancer
- Oncology Small Molecule Drugs for Multiple Myeloma
- Oncology Small Molecule Drugs for Melanoma
- Oncology Small Molecule Drugs for Lymphoma
- Oncology Small Molecule Drugs for Leukaemia
- Oncology Small Molecule Drugs for Other Indications

The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Market Insights of Oncology Small Molecule Drugs.

Key stakeholders in Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

Key Takeaways from the Market Study:

The global oncology small molecule drugs market is anticipated to add 1.8x value by 2031
Oral oncology small molecule drugs generated over US$ 56 Bn in revenue as of 2019
By drug class, targeted therapy drugs to reign supreme, capturing nearly 50% revenue
Immunomodulating drugs to hold noteworthy share, surpassing US$ 13 Bn by 2031
Non small-cell lung cancer (NSCLC) remains core indication area through 2031
U.S to account for 50% of global demand, surpassing US$ 30 Bn in 2019
China to contribute 55% of overall market revenue across the forecast period

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=3747

Competitive Landscape

Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advancements, mergers, and acquisitions.

In June 2021, Novartis AG has received breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental treatment for advanced castration-resistant prostate cancer-Novartis’ Lu-PSMA-617 – a tumour-targeting radiation therapy
In December 2019, Sanofi and Synthorx, Inc., a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement of approximately $2.5 Bn (on a fully diluted basis).

Key Parameters analyzed while estimating the Oncology Small Molecule Drugs market include:

To analyze Drugs/ Therapeutic Area in Oncology Small Molecule Drugs :Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.
To analyze Consumables of Oncology Small Molecule Drugs:

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

To analyze Oncology Small Molecule Drugs Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Some of the Oncology Small Molecule Drugs Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

Details regarding latest innovations and development in Oncology Small Molecule Drugs and how it is gaining customer traction during the forecast period.
Analysis about the customer demand of the products and how it is likely to evolve in coming years.
Latest regulations enforced by government bodies and local agencies and their impact on Demand of Oncology Small Molecule Drugs Market .
Insights about adoption of new technologies and its influence on the Oncology Small Molecule Drugs market Size.
Overview of the impact of COVID-19 on Oncology Small Molecule Drugs Market and economic disruptions caused by the pandemic.
Evaluates post-pandemic impact on the Sales of Oncology Small Molecule Drugs Market during the forecast period.

To get all-in insights on the regional landscape of the Oncology Small Molecule Drugs Market, Buy Now:-https://www.factmr.com/checkout/3747

After reading the Market insights of Oncology Small Molecule Drugs Report, readers can:

Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
Analyze key regions holding significant share of total Oncology Small Molecule Drugs market revenue.
Study the growth outlook of Oncology Small Molecule Drugs market scenario, including production, consumption, history and forecast.
Learn consumption pattern and impact of each end use & supply side analysis of Oncology Small Molecule Drugs market.
Investigate the recent R&D projects performed by each market player & competitive analysis of Oncology Small Molecule Drugs Market Players.

How Fact.MR Assists in Making Strategic Moves For Oncology Small Molecule Drugs Market Manufacturer?

The data provided in the Oncology Small Molecule Drugs market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

More Related Reports by Fact.MR On Healthcare Sector:

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Tags Oncology Small Molecule Drugs Market, Oncology Small Molecule Drugs Market Analysis, Oncology Small Molecule Drugs Market Forecast, Oncology Small Molecule Drugs Market Key players, Oncology Small Molecule Drugs Market Price, Oncology Small Molecule Drugs Market Share, Oncology Small Molecule Drugs Market Size, Oncology Small Molecule Drugs Market Trend

Pharmaceutical

Global Pediatric Neuroblastoma Treatment Market to Surge as Healthcare Workers Exercise Caution amid COVID-19 Pandemic, Says Fact.MR

Post author By administrator
Post date September 9, 2021

Pediatric Neuroblastoma Treatment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Pediatric Neuroblastoma Treatment insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Pediatric Neuroblastoma Treatment market and quantified with insightful rationale.

A comprehensive estimate of the Pediatric Neuroblastoma Treatment market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Pediatric Neuroblastoma Treatment during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4694

Global Pediatric Neuroblastoma Treatment Market Segmentation

Fact.MR has studied the global pediatric neuroblastoma treatment market with detailed segmentation on the basis of therapy type, distribution channel, and region.

Therapy-type

Immunotherapy
Chemotherapy
Others

Distribution Channel

Hospital Pharmacies
Retail Pharmacies & Drug Stores

Region

North America
Europe
Rest of the World

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4694

Key Takeaways of Global Pediatric Neuroblastoma Treatment Market Study:

By therapy type, the chemotherapy segment is anticipated to account for more than half of the global pediatric neuroblastoma treatment market. Increased usage of chemotherapy drugs such as such as cyclophosphamide, carboplatin and Doxorubicin for neuroblastoma is an important growth driver. Projected CAGR for the segment is a whopping 9.2% during the forecast period.
Immunotherapy procedures are set to surpass the chemotherapy segment. This is attributed to increased survival rates without relapse or disease progression among children. Moreover, immunotherapy procedures shall be increasingly adopted as they also offer protection from other diseases such as COVID-19. The segment shall expand impressively at a CAGR of 9.9%, accounting for more than a quarter of the market.
By distribution channel, hospitals shall continue dominating the global pediatric neuroblastoma market, capturing more than three-fifths of the market. High preference given to hospital pharmacies for dispensing specialty medicines owing to presence of trained and experienced health professionals shall leverage the segment’s prospects.
By region, North America shall dominate the global pediatric neuroblastoma treatment market, growing at an impressive CAGR of 9.0% and capturing over half of the market share. Development of technologically-enhanced products and rising approval of orphan drugs for treatment are attributed as key growth drivers.
Europe is projected to grow the fastest, owing to increased approval for new drugs, presence of important market players, rising incidences of neuroblastoma and rising awareness of good health. Projections indicate a market share of more than one-fourth of the global pediatric neuroblastoma treatment market.
In the wake of the COVID-19 pandemic, companies are increasingly leveraging their production capacities to ensure that patients suffering from neuroblastoma do not undergo complications as a result of being infected by the virus. Studies have shown that, fortunately, the COVID-19’s impact is restricted to adults. However, practitioners have urged manufacturers to conduct in-depth research on the virus’s impact on pediatric patients in order to develop a response mechanism should an infection arise.
APEIRON Biologics, an important market player, has initiated phase II of its APN01 drug for treating the COVID-19 disease. The drug candidate is designed to imitate human ACE2 used by the virus to enter host cells to inhibit infection and reduce lung injury. Likewise, Pfizer Inc., another neuroblastoma player, has collaborated with BioNTech to develop the BNT162 mRNA vaccine for eradicating COVID-19.

To get all-in insights on the regional landscape of the Pediatric Neuroblastoma Treatment Market, Buy Now:-https://www.factmr.com/checkout/4694

After reading the Market insights of Pediatric Neuroblastoma Treatment Report, readers can:

Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
Analyze key regions holding significant share of total Pediatric Neuroblastoma Treatment market revenue.
Study the growth outlook of Pediatric Neuroblastoma Treatment market scenario, including production, consumption, history and forecast.
Learn consumption pattern and impact of each end use & supply side analysis of Pediatric Neuroblastoma Treatment market.
Investigate the recent R&D projects performed by each market player & competitive analysis of Pediatric Neuroblastoma Treatment Market Players.

How Fact.MR Assists in Making Strategic Moves For Pediatric Neuroblastoma Treatment Market Manufacturer?

The data provided in the Pediatric Neuroblastoma Treatment market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

More Related Reports by Fact.MR On Healthcare Sector:

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Tags Pediatric Neuroblastoma Treatment Market, Pediatric Neuroblastoma Treatment Market Analysis, Pediatric Neuroblastoma Treatment Market Forecast, Pediatric Neuroblastoma Treatment Market Key players, Pediatric Neuroblastoma Treatment Market Price, Pediatric Neuroblastoma Treatment Market Share, Pediatric Neuroblastoma Treatment Market Size, Pediatric Neuroblastoma Treatment Market Trend

Pharmaceutical

Demand for PCR Diagnostic Technology to Continue Upward Trend in Oncology Molecular Diagnostic Market, Says Fact.MR

Post author By administrator
Post date September 9, 2021

Oncology Molecular Diagnostic Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Oncology Molecular Diagnostic insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Oncology Molecular Diagnostic market and quantified with insightful rationale.

A comprehensive estimate of the Oncology Molecular Diagnostic market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Oncology Molecular Diagnostic during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=6864

Key Segments Covered in Oncology Molecular Diagnostic Industry Research

By Product
- Oncology Molecular Diagnostic Reagents & Kits
- Oncology Molecular Diagnostic Instruments
  - Oncology Molecular Diagnostic Tabletop Instruments
  - Oncology Molecular Diagnostic Portable & PoC Instruments
- Oncology Molecular Diagnostic Services & Software
By Technology
- Polymerase Chain Reaction (PCR) in Oncology Molecular Diagnostics
- Isothermal Nucleic Acid Amplification Technology (INAAT) for Oncology Molecular Diagnostics
- DNA Sequencing & Next-Generation Sequencing (NGS) for Oncology Molecular Diagnostics
- In Situ Hybridization (ISH) Technology for Oncology Molecular Diagnostics
- DNA Chips and Microarrays for Oncology Molecular Diagnostics
By End User
- Oncology Molecular Diagnostic Used in Diagnostic Laboratories
- Oncology Molecular Diagnostic Used in Hospitals & Clinics

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=6864

Key Takeaways from Market Study

Global oncology molecular diagnostic market is expected to grow 2.3X in value by 2031.
Demand for reagents & kits to expand at a CAGR of 12.8% over next ten years.
Market in China anticipated to reach a valuation of US$ 670 Mn by 2031.
Markets in Japan and Canada forecasted to grow 8% and 9%, respectively.
Demand for PCR diagnostic technology to dominate the market over next ten years.

Key Parameters analyzed while estimating the Oncology Molecular Diagnostic market include:

To analyze Drugs/ Therapeutic Area in Oncology Molecular Diagnostic :Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.
To analyze Consumables of Oncology Molecular Diagnostic:

To analyze Oncology Molecular Diagnostic Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Some of the Oncology Molecular Diagnostic Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

Details regarding latest innovations and development in Oncology Molecular Diagnostic and how it is gaining customer traction during the forecast period.
Analysis about the customer demand of the products and how it is likely to evolve in coming years.
Latest regulations enforced by government bodies and local agencies and their impact on Demand of Oncology Molecular Diagnostic Market .
Insights about adoption of new technologies and its influence on the Oncology Molecular Diagnostic market Size.
Overview of the impact of COVID-19 on Oncology Molecular Diagnostic Market and economic disruptions caused by the pandemic.
Evaluates post-pandemic impact on the Sales of Oncology Molecular Diagnostic Market during the forecast period.

To get all-in insights on the regional landscape of the Oncology Molecular Diagnostic Market, Buy Now:-https://www.factmr.com/checkout/6864

Competitive Landscape

Top service providers of oncology molecular diagnostics, in an attempt to gain stability, are adopting strategies such as specialized product development. Leading market players in oncology molecular diagnostics are also entering into collaborations with top oncology molecular diagnostic instrument brands, for development of companion diagnostic pertaining to cancer.

Some of the key developments are:

In September 2015; Roche launched the Cobas EGFR Mutation Test v2, which is used for diagnosis of Non-Small Cell Lung Cancer (NSCLC), which is expected to drive the growth of this market.
Qiagen and Lilly announced their plans to co-develop companion diagnostics for targeting common cancer biomarkers.
In February 2019, ICON plc, a US-based biotechnology company, acquired MolecularMD for an undisclosed amount. The acquisition enhances ICON’s laboratory offering in molecular diagnostic testing and brings to ICON expanded testing platforms, including next-generation sequencing, and immunohistochemistry (IHC).

How Fact.MR Assists in Making Strategic Moves For Oncology Molecular Diagnostic Market Manufacturer?

The data provided in the Oncology Molecular Diagnostic market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

More Related Reports by Fact.MR On Healthcare Sector:

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Tags Oncology Molecular Diagnostic Market, Oncology Molecular Diagnostic Market Analysis, Oncology Molecular Diagnostic Market Forecast, Oncology Molecular Diagnostic Market Key players, Oncology Molecular Diagnostic Market Price, Oncology Molecular Diagnostic Market Share, Oncology Molecular Diagnostic Market Size, Oncology Molecular Diagnostic Market Trend

Pharmaceutical

Biomedical Refrigerators and Freezers Market is Expected to Witness Healthy Growth at 5.7% CAGR through 2031

Post author By administrator
Post date September 9, 2021

Biomedical Refrigerators and Freezers Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Biomedical Refrigerators and Freezers insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Biomedical Refrigerators and Freezers market and quantified with insightful rationale.

A comprehensive estimate of the Biomedical Refrigerators and Freezers market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Biomedical Refrigerators and Freezers during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=343

Market Taxonomy

Region	North America Latin America Europe Japan APEJ MEA
Product Type	Blood Bank Refrigerators Laboratory Refrigerators Plasma Freezers Ultra-Low Freezers Laboratory Freezers Shock Freezers Cryogenic Storage Systems
End User	Hospitals Pharmacies Diagnostic Centers Research Laboratories Blood Banks

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=343

Competition Tracking

Leading market players operating in the global biomedical refrigerators and freezers market include

Aegis Scientific Inc.
Arctiko A/S
Binder GmbH
Biomedical Solutions Inc.
Bionics Scientific Technologies Co. Ltd.
Coldway SA
Desmon S.p.A
Eppendorf AG
Froilabo SAS
Gram Commercial SAS
Helmer Inc.
LabRepco Inc.
Liebherr International AG
Panasonic Healthcare Co. Ltd.
Philips Kirsch GmbH
Terumo Corporation
Thermofisher Scientific Inc.

Some of the Biomedical Refrigerators and Freezers Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

Details regarding latest innovations and development in Biomedical Refrigerators and Freezers and how it is gaining customer traction during the forecast period.
Analysis about the customer demand of the products and how it is likely to evolve in coming years.
Latest regulations enforced by government bodies and local agencies and their impact on Demand of Biomedical Refrigerators and Freezers Market .
Insights about adoption of new technologies and its influence on the Biomedical Refrigerators and Freezers market Size.
Overview of the impact of COVID-19 on Biomedical Refrigerators and Freezers Market and economic disruptions caused by the pandemic.
Evaluates post-pandemic impact on the Sales of Biomedical Refrigerators and Freezers Market during the forecast period.

To get all-in insights on the regional landscape of the Biomedical Refrigerators and Freezers Market, Buy Now:-https://www.factmr.com/checkout/343

After reading the Market insights of Biomedical Refrigerators and Freezers Report, readers can:

Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
Analyze key regions holding significant share of total Biomedical Refrigerators and Freezers market revenue.
Study the growth outlook of Biomedical Refrigerators and Freezers market scenario, including production, consumption, history and forecast.
Learn consumption pattern and impact of each end use & supply side analysis of Biomedical Refrigerators and Freezers market.
Investigate the recent R&D projects performed by each market player & competitive analysis of Biomedical Refrigerators and Freezers Market Players.

Market Players

Major players in the global market of biomedical refrigerators and freezers are Arctiko A/S, Aegis Scientific, Inc., Biomedical Solutions Inc., Binder GmbH, Coldway SA, Bionics Scientific Technologies Co., Ltd., Eppendorf AG, Desmon S.p.A, Gram Commercial SAS, Froilabo SAS, Liebherr International AG, LabRepco Inc., Philips Kirsch GmbH, Panasonic Healthcare Co., Ltd., Thermofisher Scientific Inc. and Terumo Corporation.

How Fact.MR Assists in Making Strategic Moves For Biomedical Refrigerators and Freezers Market Manufacturer?

The data provided in the Biomedical Refrigerators and Freezers market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

More Related Reports by Fact.MR On Healthcare Sector:

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Tags Biomedical Refrigerators and Freezers Market, Biomedical Refrigerators and Freezers Market Analysis, Biomedical Refrigerators and Freezers Market Forecast, Biomedical Refrigerators and Freezers Market Key players, Biomedical Refrigerators and Freezers Market Price, Biomedical Refrigerators and Freezers Market Share, Biomedical Refrigerators and Freezers Market Size, Biomedical Refrigerators and Freezers Market Trend

Pharmaceutical

Rising Demand for Tracheostomy Instruments Is Expected to Boost the Growth of the Reusable Tracheostomy Tray

Post author By administrator
Post date September 9, 2021

Tracheostomy trays are specially designed trays, inclusive of all the essential wound dressing components for the management and treatment of tracheostomized patients. A tracheostomy tray comprises an inner cannula which is disposable. Tracheostomy trays are ready to use as they are sterilized at the time of packing only. The rising demand for tracheostomy instruments and tracheostomy procedures is expected to boost the growth of the tracheostomy tray market.Tracheostomy trays consist of nitrile gloves, trach brush, drape, twill tape roll, cotton tip applicators, pipe cleaners, gauze sponges, removable basin, retractor, dilator, scalpel knife- handle for surgical blade, artery forceps, scissors, needle holder, blunt hook retractor, dressing forceps, etc.

To remain ‘ahead’ of your competitors, request a Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=1724

Tracheostomy trays offer great convenience and rapid access to wound care items, as tracheostomy is also performed in case of an emergency and trauma. Tracheostomy is a surgical procedure which involves creating a hole through a patient’s trachea (windpipe). The tracheostomy procedure allows the passage of air when the common breathing pathway is obstructed or damaged. A tracheostomy is frequently performed when there is obstruction in the upper airways of the respiratory tract, impaired respiratory function, or cleaning secretions from the upper respiratory airway. The most common conditions that require emergency tracheostomy include upper airway obstruction after accidents, gastrointestinal bleeding, inhalation of smoke at fire incidences, etc.

Tracheostomy Tray Market: Drivers and Restraints

Tracheostomy trays are a common choice of instrument combination in a tracheostomy surgical procedure or patient care management in tracheostomy operated patients. The tracheal rings below the cricoid cartilage is the most preferred location utilized to perform a tracheostomy, due to ease of access. A tracheostomy tray constitutes primary care products such as a trachea retractor, suction tubes, and an inner/outer cannula.

Tracheostomy instruments are essential to control the condition of obstruction in airways in patients. The rising demand for tracheostomy instruments and tracheostomy procedures is expected to boost the growth of the tracheostomy tray market. Rising incidences of upper airway obstruction in the general population, coupled with surgical procedures involving pulmonary ventilation and pulmonary toilet is anticipated to drive the growth of the tracheostomy tray market. Tracheostomy trays are safe and ensure quick surgical procedural response. Along with these, tracheostomy trays are cost-effective and have high sterilization levels. All these factors act as a potential driver for the burgeoning growth of the tracheostomy tray market.

Tracheostomy Tray Market: Segmentation

Based on product type, the tracheostomy tray market is segmented into:

Reusable
Disposable

Based on end user, the tracheostomy tray market is segmented into:

Hospitals
Clinics
Trauma Centers
Emergency Departments
Ambulatory Surgical Centers

Tracheostomy Tray Market: Overview

The global tracheostomy tray market has observed a robust growth, due to the increasing demand for tracheostomy trays in performing tracheostomy procedures in various conditions. Although, in case of an emergency, tracheostomy is not performed as there is a high risk of complications. A relatively low risk procedure called cricothyrotomy is performed. The tracheostomy tray market has a presence of several players. The increasing incidents of respiratory trauma and growing number bedridden patients on ventilators is anticipated to act as a major factor fueling the tracheostomy tray market.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1724

Tracheostomy Tray Market: Region-Wise Overview

The global tracheostomy tray market is segmented into the following regions – North America, Latin America, Europe, CIS & Russia, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa. North America is the dominant regional market for tracheostomy trays, due to high medical standards in the region. In North America, the U.S. is the dominating market, due to the inclination towards disposable medical instrument utilization. Europe is the second-most dominating regional market for tracheostomy trays, due to the high awareness among end users. APAC is a fast-growing regional market for tracheostomy trays, due to the increasing demand for standard medical care instruments. Growth in Latin America and the Middle East and Africa is increasing slowly, due to increasing healthcare spending and standards.

Tracheostomy Tray Market: Key Participants

Examples of some of the key participants in the tracheostomy tray market are Smiths Medical, Cardinal Healthcare Group, Inc., Robert Busse & Co., Inc., Vyaire Medical, Inc., Medline Industries, Inc., McKesson Medical-Surgical Inc., Centurion Medical Products Corporation, Cypress Medical Products LLC, Dynarex Corporation, Covidien Ltd., Amsino International, Inc., and Sunset Healthcare Solutions Inc., among others.

The research report presents a comprehensive assessment of the market, and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, product type, and end user.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain

For More Insights https://www.biospace.com/article/benign-positional-vertigo-treatment-demand-propelled-by-increasing-number-of-patients-visiting-for-bppv-treatment-says-fact-mr/

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep., etc.), and Rest of Europe
CIS & Russia
Japan
APEJ (Greater China, India, S. Korea, ASEAN Countries, and Rest of APEJ)
Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Tracheostomy Tray Market, Tracheostomy Tray Market Insight, Tracheostomy Tray Market report, Tracheostomy Tray Market share, Tracheostomy Tray Market size

Pharmaceutical

Non-Radiographic Axial Spondyloarthritis (axSpA) Market Key Players, End User, Demand and Consumption By 2030

Post author By administrator
Post date September 9, 2021

A new research report published by Fact.MR on the Axial Spondyloarthritis (axSpA) Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the historical period. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues during the forecast period 2020 to 2030.

The insights and analytics on the Axial Spondyloarthritis (axSpA) Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

Key stakeholders in the Axial Spondyloarthritis (axSpA) Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities. Many in recent months have overhauled their strategies to remain agile in the backdrop of worldwide disruptions caused by the COVID-19 pandemic.

To remain ‘ahead’ of your competitors, request for a Brochure https://www.factmr.co/connectus/sample?flag=B&rep_id=5272

The following insights and evaluations are worth knowing for any market participant, helping them in ascertaining the prevailing dynamics and the future trajectories of the Axial Spondyloarthritis (axSpA) Market. They are a part of the estimations of the opportunities in various segments:

Changing consumer preferences and uptake trends in key industries
Key trends highlighting funding by top investors in various countries
Changing demand and consumption of various product segments
New avenues for investments in various technology and product/service types
Recent regulations in key industries affecting the demand in the Axial Spondyloarthritis (axSpA) Market
Detailed profiling of various players

Axial Spondyloarthritis (axSpA) Market: Segmentation

Tentatively, the global Axial Spondyloarthritis (axSpA) Market has been segmented on the basis of stages, drug-class and distribution channel.

Based on stages, the global Axial Spondyloarthritis (axSpA) Market is segmented as:

ankylosing spondylitis
non-radiographic axial spondyloarthritis

Based on Drug class, the global Axial Spondyloarthritis (axSpA) Market is segmented as:

non-steroidal anti-inflammatory drugs (NSAID)
anti-rheumatic drugs
glucocorticoids
TNFα inhibitors

Based on distribution channel, the global Axial Spondyloarthritis (axSpA) Market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

What insights readers can gather from the Axial Spondyloarthritis (axSpA) Market report?

Learn the strategies, and modus operandi of every Axial Spondyloarthritis (axSpA) Market player –expansions, product launches, collaborations and acquisitions in the market currently
Enter the market with an objective view of of the progress outlook of the global Axial Spondyloarthritis (axSpA) landscape, including total revenue, consumption and production, and historical & forecast
Get your hands on key drivers, opportunities, challenges to growth and trends (DROT Analysis)
Get a sneak-peek of trends, R&D developments, such as carbon footprint, prototype technologies, and globalization

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=5272

Regional Segments Analyzed Include

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

The Axial Spondyloarthritis (axSpA) Market report answers the following queries:

What is the largest share held by key players in the market?
What strategies have proven most advantageous in the Axial Spondyloarthritis (axSpA) Market?
Which region promises largest opportunity for new investors during the forecast period 2020 to 2030?
What factors will most likely present challenges to growth during the forecast period?
What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2020 to 2030?

What Do You Get in a Fact.MR Study?

Factors affecting the overall development of the global Axial Spondyloarthritis (axSpA)
Factor that might restrain the growth of the global market in the coming years of the forecast period 2020 to 2030
What is present competitive scenario of the global Axial Spondyloarthritis (axSpA) Market and its intricate details concerning potential business prospects of leading market players
Pricing strategies of several different market players in the global Axial Spondyloarthritis (axSpA)

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies in the World. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

For More Insights https://www.biospace.com/article/increasing-level-of-research-and-studies-helping-to-spread-awareness-about-intra-amniotic-infection-treatment-market/

Why Choose Fact.MR?

Deliver updated information on the current industry trends
Available 24/7 to facilitate clients with unbiased solutions
Embrace digital technologies to offer accurate business ideas
Exhaustive supply chain augmentation analysis
Provide reports strictly according to the requirements of the clients

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Axial Spondyloarthritis Market, Axial Spondyloarthritis Market forecast, Axial Spondyloarthritis Market insight, Axial Spondyloarthritis Market size, Axial Spondyloarthritis Market trends, axSpA market

Pharmaceutical

Orthogonathic Surgery Market to Record Exponenetial Growth Owing to High Demand Through COVID-19 Pandemic

Post author By administrator
Post date September 9, 2021

Orthopedic repair is also called orthopedic surgery or orthopedics, which is a branch of medicine that deals with the conditions involving the musculoskeletal system. Orthopedic doctors use both, surgical and non-surgical means to treat musculoskeletal anomalies, spinal anomalies, and sports and trauma injuries. Orthopedic repair is basically performed on the musculoskeletal system. This includes the bones, joints, muscles, ligaments, cartilages, nerves, and connective tissues which bind various parts of the body together. Global market for orthopedic repair is expected to witness moderate growth over the forecast period

A musculoskeletal anomaly in any part of the body can have an enormous impact on an individual’s day-to-day activities. There are a range of treatments in order to correct such problems. The most common treatment method for various orthopedic injuries and conditions is the construction and repair of the injured body part with a surgery. Surgical construction and repair of a joint, bone, muscle, cartilage or nerve can be completed with various procedures like fusion, internal fixation, osteotomy, soft tissue repair, and arthroscopy.

To remain ‘ahead’ of your competitors, request a Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=1501

Orthopedic Repair Market: Drivers and Restraints

The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the orthopedic repair market over the forecast period. It is anticipated that several areas will affect the orthopedic repair market. Patient-specific surgeries and implants are expected to drive the orthopedic repair market. Various tools have been developed in the orthopedic repair market in order to improve accuracy, and also by customizing surgical cutting blocks to a patient’s anatomy. In personalized healthcare, various surgeries in the orthopedic repair market, such as spinal, maxillofacial, and prosthetic devices will drive the orthopedic repair market. However, high prices and lack of awareness in developing economies are expected to hinder the growth of the orthopedic repair market.

Orthopedic Repair Market: Segmentation

Tentatively, the global orthopedic repair market can be segmented on the basis of surgery type, end user, and geography.

Based on surgery type, the global orthopedic repair market is segmented as:

Upper Extremity
- Shoulder Anthroscopy
- Shoulder Surgery
- Maxillofacial Surgery
- Shoulder Replacement
- Orthogonathic Surgery
- Hand Surgery
- Wrist Surgery
Lower Extremity
- Anterior Crutiate Ligament Reconstruction
- Knee Replacement Surgery
- Tibial Nailing
- Minimally Invasive Forefoot Surgery
- Femoral Fracture Surgery
- Meniscal Transplantation
- Hip Surgery
- Hip Replacement
Spinal Surgery
- Spinal Surgery
- Spinal Osteosynthesis Surgery
- Percutaneous Kyphoplasty
- Percutaneous Vertebroplasty
- Inter-body Fusion Surgery
Bones
- Bone Cement Injection
- Bone Grafting
Traumatology

Based on end user, the global orthopedic repair market is segmented as:

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers
Trauma Centers

Based on geography, the global orthopedic repair market is segmented as:

North America
- S.
- Canada

Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Peru
- Rest of LATAM
Europe
- EU – 4 (Germany, France, Italy, Spain)
- K.
- BENELUX (Belgium, Netherlands, Luxemburg)
- NORDIC (Norway, Denmark, Iceland, Sweden)
- Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
- Rest of Europe

CIS & Russia

Japan

APEJ
- Greater China
- India
- Korea
- ASEAN Countries
- Rest of APEJ

Middle East & Africa
- GCC Countries
- Turkey
- Iran
- Israel
- South Africa
Rest of MEA

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1501

Orthopedic Repair Market: Overview

The global market for orthopedic repair is expected to witness moderate growth over the forecast period. A majority of the surgeries are readily available in various hospitals, orthopedic clinics, ambulatory surgical centers, and specialty clinics. Amongst the end users in Orthopedic Repair market, the hospitals and ambulatory surgical centers segments are expected to lead in the global orthopedic repair market over the forecast period. Amongst the surgery types, the global orthopedic repair market is expected to be dominated by spinal and lower extremity surgeries, owing to the increasing incidences of spinal and lower extremity anomalies.

Orthopedic Repair Market: Regional Outlook

Geographically, the global orthopedic repair market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global orthopedic repair market, owing to the high prevalence of orthopedic anomalies. The orthopedic repair market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global orthopedic repair market throughout the forecast period.

For More Insights: https://www.biospace.com/article/growing-number-of-regulatory-approvals-will-aid-growth-of-the-global-diabetic-neuropathy-market/

Orthopedic Repair Market: Key Players

The global market for Orthopedic Repair Market is highly fragmented. Examples of some of the key players operating in the global orthopedic repair market are

Zimmer Biomet
Z-Medical GmbH + Co. KG
USTOMED INSTRUMENTE
Synimed Synergie Ingénierie Médicale SARL
Stryker Corporation
Joline GmbH & Co. KG
JEIL MEDICAL CORPORATION
iMEDICOM
EgiFix Medical

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Orthopedic Repair Market, Orthopedic Repair Market Insight, Orthopedic Repair Market report, Orthopedic Repair Market share, Orthopedic Repair Market size

Route of Administration

Drug Class

Distribution Channel

Indication

By Product

By Technology

By End User